First human tests begin for new sepsis drug
Disease control
Not yet recruiting
This is an early safety study for a new drug called OPT101, designed for adults hospitalized with pneumonia that has led to sepsis. The main goal is to see if the drug is safe and how it moves through the body in this seriously ill group. Researchers will compare the drug to a pl…
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC